X @BSCN

Onchain Pre-IPO Trading - Injective Protocol launched onchain pre-IPO perpetual markets, enabling trading of synthetic shares of private firms like OpenAI [1] - Traders can take leveraged positions up to 5x on company valuations directly on Injective [1] - These markets operate fully onchain, utilizing data from Seda Protocol and Caplight [1] Market Expansion and Asset Tokenization - OpenAI is the first listing on Helix, with Monzo, xAI, and Revolut to follow in October [2] - Injective aims to "bring every financial market onchain," aligning with the surge in real-world asset tokenization past $30 billion this year [2] - Injective's model expands pre-IPO access to retail users globally, though synthetic shares don't grant ownership rights [3] Real-World Asset (RWA) Integration - The move signifies a deeper push into real-world assets, following Injective's $1 billion in RWA perpetual futures trading in the past month [3] - Perpetuals differ from standard futures by having no expiry date, allowing indefinite exposure to company valuations ahead of IPOs [2]